Paul Black

Title: Paul Black: Innovator in Fatty Acid Transport Inhibition

Introduction

Paul Black is a notable inventor based in Slingerlands, NY (US). He has made significant contributions to the field of fatty acid transport inhibitors. His innovative work has led to the development of a unique patent that addresses important aspects of fatty acid uptake.

Latest Patents

Paul Black holds a patent titled "System for screening fatty acid transport inhibitors, methods of use and modulators identified thereby." This patent outlines methods for identifying modulators of fatty acid transport and/or uptake. The process involves contacting a putative modulator with a system that includes genetic material encoding a fatty acid transport mediator. The mediators include FAA1, FAA2, FAA3, FAA4, FAT1, fadL, fadD, FATP, CD36, and FABP, among others. The patent also describes the use of fatty acid transport mediator proteins and the determination of the effect of the putative modulator.

Career Highlights

Paul Black is currently associated with the Clf Medical Technology Acceleration Program, Inc. His work in this organization focuses on advancing medical technology through innovative solutions. His expertise in fatty acid transport has positioned him as a key figure in this field.

Collaborations

Paul Black collaborates with Concetta DiRusso, contributing to the advancement of research in fatty acid transport and its implications in medical technology.

Conclusion

Paul Black's contributions to the field of fatty acid transport inhibitors highlight his innovative spirit and dedication to advancing medical technology. His patent serves as a testament to his expertise and commitment to improving health outcomes.